NewsFlash Archive

more Events

  • 0%
    0 votes

    Study Explains Why Alzheimer's Drug Is Both Safe and Effective

    Thursday, August 19, 2010

    Alzheimer's disease destroys brain cells and their connections (called synapses), causing memory loss and other cognitive problems that disrupt work, hobbies and daily lifeSymptoms can be alleviated, in part, by the drug memantine (marketed in the United States as Namenda), which is currently FDA-

    read more>>

  • 0%
    0 votes

    Study Sheds Light on Cancer-Causing Gene Regulation

    Wednesday, August 18, 2010

    BOSTON -- Researchers at Beth Israel Deaconess Medical Center (BIDMC) have uncovered the genes that regulate MDM2, an oncogene that, in turn, regulates the tumor suppressor protein p53But instead of an on-off switch for MDM2, the team found what looks like a dimmer switch, suggesting a more compli

    read more>>

  • 0%
    0 votes

    Evolution May Have Pushed Humans Toward Greater Risk for Type 1 Diabetes, Stanford Study Shows

    Wednesday, August 18, 2010

    STANFORD, Calif. -- Gene variants associated with an increased risk for type-1 diabetes and rheumatoid arthritis may confer previously unknown benefits to their human carriers, say researchers at the Stanford University School of MedicineAs a result, the human race may have been evolving in the re

    read more>>

  • 0%
    0 votes

    TAU Develops Genetically Mutated Stem Cells for Myelin Research

    Wednesday, August 18, 2010

    Vanishing White Matter (VWM) disease is a devastating condition that involves the destruction of brain myelin due to a mutation in a central factorTo understand the disease and test potential treatments that could apply to other disorders, such as multiple sclerosis, Prof. Orna Elroy-Stein of Tel

    read more>>

  • 0%
    0 votes

    New Mechanisms of Tumor Resistance to Targeted Therapy in Lung Cancer Are Discovered

    Wednesday, August 18, 2010

    Cold Spring Harbor, NY -- One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of timeA

    read more>>

  • 0%
    0 votes

    ISU Researchers Discover Cause of Immune System Avoidance of Certain Pathogens

    Wednesday, August 18, 2010

    AMES -- A special set of sugars found on some disease-causing pathogens helps those pathogens fight the body's natural defenses as well as vaccines, say two Iowa State University researchersThis discovery may be a first step in understanding a disease family that includes tuberculosis for which th

    read more>>

  • 0%
    0 votes

    Boston University, Veterans Affairs Find Sports Brain Trauma May Cause Disease Mimicking ALS

    Wednesday, August 18, 2010

    BOSTON -- The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) and Department of Veterans Affairs (VA) announced today that they have provided the first pathological evidence that repetitive head trauma experienced in collision sports is The mo

    read more>>

  • 0%
    0 votes

    Gallbladder Cancer May Be Linked to Estrogens, Says UH Team

    Tuesday, August 17, 2010

    HOUSTON -- A very aggressive disease with a poor prognosis, gallbladder cancer may be connected to higher exposure to estrogens, according to a group of researchers at the University of Houston (UHDr. Jan-Åke Gustafsson, Robert A. Welch Professor in UH's biology and biochemistry department,

    read more>>

  • 0%
    0 votes

    Scientists Reveal New Targets for Anti-Angiogenesis Drugs

    Tuesday, August 17, 2010

    BOSTON -- A new study describes how a carbohydrate-binding protein, galectin-3, promotes angiogenesis, the growth of new blood vesselsTargeting the protein, scientists identified two approaches that significantly reduced angiogenesis in mice. These discoveries, published online August 16 in The Jo

    read more>>

  • 0%
    0 votes

    Sensing a Breakthrough

    Tuesday, August 17, 2010

    When researchers pinpointed the genetic mutation that leads to the disease known as facioscapulohumeral dystrophy (FSHD) in 1992, hopes rose that the discovery not only would result in better treatments but also eventually a cure for the diseaseBut FSHD, which was first described by French physici

    read more>>